Subscribe
JHVEPhoto / Shutterstock.com
29 October 2025NewsAmericasMuireann Bolger

‘We're being attacked from all sides’: Thermo Fisher Scientific counsel

With fraudsters exploiting new technologies, the company’s Kenya Williams explains why vigilant enforcement is money well spent to maintain a ‘clean’ brand.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
LSPN panel unpacks critical IP risks in deal-making
23 October 2025   Experts at LSPN North America Fall explore the often-overlooked factors that can make or break transactions, from employee retention strategies to cross-border patent standards.
Americas
Top pharma, biotech, and medtech experts gather at LSPN Fall
21 October 2025   LSIPR is gearing up for the 5th annual LSPN North America Fall Conference, starting October 21, in San Francisco, California.
Europe
Budgets, CRISPR, and keeping pace with tech: top challenges for Europe’s patent pros
25 September 2025   A new survey from LSIPR reveals that European patent practitioners are grappling with client budget constraints and fast-evolving technologies, with most expecting patenting challenges to increase over the next five years.


Editor's picks

Why AI is changing the patent rules faster than anyone can keep up
Americas
Why AI is changing the patent rules faster than anyone can keep up
24 October 2025

Editor's picks

Americas
Why AI is changing the patent rules faster than anyone can keep up
24 October 2025
Americas
A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order
23 October 2025
Americas
Data and delivery: Inside AI's inventorship dilemma
21 October 2025
Americas
Top pharma, biotech, and medtech experts gather at LSPN Fall
21 October 2025
Big Pharma
Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’
16 October 2025
Americas
‘Death knell’ for investment: Universities warn against Lutnick’s royalty sharing proposal
13 October 2025

More features

China trademarks rankings reveal new entries, hidden gems and big brands
Edwards defends key heart valve product from infringement threat
Is AI emerging as the ‘fourth party’ solving billion-dollar disputes?
The hidden code in life sciences deals
Why AI is changing the patent rules faster than anyone can keep up
LSPN panel unpacks critical IP risks in deal-making
A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order
Less is more: patent lawyers flip the script after Amgen